AMSTERDAM, October 8, 2013 /PRNewswire/ --
7,500 book titles indexed in Scopus; another 75,000 to be added over the next 3 years
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that Scopus has indexed the first 7,500 book titles as part of its Book Titles Expansion program. By 2015, an estimated 75,000 book titles will be indexed. The inclusion of book titles adds to the more than 50 million records indexed by Scopus which are derived from 20,000 journals, 5.5 million conference proceedings and 390 trade publications.
Each scholarly publication type - journals, conference proceedings and books - may be cited and referenced and therefore contributes to the evaluation of the impact of research. In addition to increasing the breadth and depth of Scopus' reach in scholarly content, the inclusion of book titles ensures that Scopus more effectively meets both the discoverability and evaluation needs of book-based disciplines in the social sciences and arts and humanities.
"With its broad reach of academic content, Scopus has become one of the most popular abstract and citation databases amongst researchers and those who evaluate both researchers and the impact of scientific output," said Cameron Ross, Vice President of Product Management, Scopus & Engineering Village at Elsevier. "The addition of book titles in Scopus not only makes this content more discoverable while strengthening certain subject fields, it also further enhances the Author Profiles and h-index of researchers working in subject areas where books are important."
Dr. Henk Moed, Senior Scientific Advisor for Elsevier said, "Especially in social sciences and humanities, as well as in applied sciences and engineering, monographs, multi-authored books, and reference works are important publication types for scholarly communication. Inclusion of book titles in Scopus will increase the subject coverage of these domains of scholarship, and the visibility of their connections with other scientific disciplines."
All titles in the Scopus Book Titles Expansion Program are included - at no additional fee - under the standard Scopus license.
About Scopus
Scopus, the largest abstract and citation database of peer-reviewed literature, features smart tools to track, analyze and visualize scholarly research. Its vast database contains abstracts and references from 21,000 titles from more than 5,000 publishers worldwide, ensuring broad interdisciplinary coverage in the fields of science, technology, medicine, social sciences and Arts & Humanities. Scopus was designed and developed with input from researchers and librarians internationally; and features direct links to subscribed full-text articles, other library resources and interoperability with applications such as reference management software.
About Elsevier
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby's Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group PLC is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.
Media contact
Elizabeth Dyas
Elsevier
+31-20-485-2273
[email protected]
SOURCE Elsevier
Share this article